Artery Stenosis Drug Market 2020-2027 Moving Towards Brighter openpr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from openpr.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
ResearchAndMarkets.com s offering.
The global multiple myeloma drugs market grew at a CAGR of around 9% during 2014-2019. Multiple myeloma, or Kahler s disease, refers to a form of blood cancer that primarily affects the plasma cells. Some of the most common types of multiple myeloma drugs include chemotherapeutic agents, corticosteroids and immunomodulatory agents. These pharmaceutical drugs aid in promoting bone healing, prevent hypercalcemia, bone fracture, spinal cord compression and anemia, while minimizing the need for chemotherapy. The chemotherapeutic agents include various anthracycline antibiotics and alkylating agents, such as melphalan, doxorubicin, vincristine and liposomal doxorubicin. The targeted therapy drugs include proteasome inhibitor, such as bortezomib, and various other compounds, including dexamethasone, prednisone and thalidomide.
Global Denture Adhesive Market 2020 - 2025 Research Report Segment Outlook, Growth Potentials and Analysis of COVID-19 Worldwide Outbreak marketwatch.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketwatch.com Daily Mail and Mail on Sunday newspapers.
Search jobs 11-Dec-2020 Pediatric Vaccine Market Size to grow at a CAGR of 14.4% by 2027 | Coherent Market Insights
The Centers for Disease Control and Prevention (CDC) recommends pneumococcal conjugate vaccine for all children younger than 2 years old. Other vaccines for infants include, Hepatitis B vaccine, flu vaccine, and human papillomavirus vaccine.
The global pediatric vaccine market is estimated to account for US$ 37,567 Mn in terms of value in 2019 and is expected to reach
US$ 98,859 Mn by the end of 2027.
Global Pediatric Vaccine Market:
Drivers
Increasing funding related to vaccines is expected to boost growth of the global pediatric vaccines market over the forecast period. For instance, in January 2020, Codagenix, a company focused on R&D of vaccines and viral therapies raised US$ 20 million in a new round of financing led by Adjuvant Capital.
Crescendo Biologics Ltd: Crescendo Biologics Expands its Ongoing Collaboration with Takeda
Crescendo Biologics Ltd (Crescendo), the drug developer of novel, targeted T cell enhancing therapeutics, today announced that it has expanded its global, multi-target discovery and development collaboration with Takeda Pharmaceutical Company Limited (Takeda) after Crescendo achieved its sixth technical milestone.
Under its ongoing collaboration and license agreement, Crescendo s proprietary transgenic platform and engineering expertise is being used to build Humabody
-based therapeutics against certain targets selected by Takeda.
The collaboration expansion gives Takeda access to a range of Crescendo s half-life extension Humabodies for use with its two Humabody programmes, previously licensed in November 2018 and July 2019, and Humabody programmes Takeda licenses in the future during the term of the collaboration expansion.